midazolam has been researched along with Postpartum Hemorrhage in 2 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Postpartum Hemorrhage: Excess blood loss from uterine bleeding associated with OBSTETRIC LABOR or CHILDBIRTH. It is defined as blood loss greater than 500 ml or of the amount that adversely affects the maternal physiology, such as BLOOD PRESSURE and HEMATOCRIT. Postpartum hemorrhage is divided into two categories, immediate (within first 24 hours after birth) or delayed (after 24 hours postpartum).
Excerpt | Relevance | Reference |
---|---|---|
"To compare the efficacy of dexmedetomidine and midazolam in the prevention of postoperative nausea and vomiting (PONV) caused by hemabate in postpartum hemorrhage during cesarean delivery." | 9.34 | A Comparison of Dexmedetomidine and Midazolam for the Prevention of Postoperative Nausea and Vomiting Caused by Hemabate in Cesarean Delivery: A Randomized Controlled Trial. ( Hu, B; Li, X; Shi, J; Tan, L; Zhou, H; Zou, X, 2020) |
"To compare the efficacy of dexmedetomidine and midazolam in the prevention of postoperative nausea and vomiting (PONV) caused by hemabate in postpartum hemorrhage during cesarean delivery." | 5.34 | A Comparison of Dexmedetomidine and Midazolam for the Prevention of Postoperative Nausea and Vomiting Caused by Hemabate in Cesarean Delivery: A Randomized Controlled Trial. ( Hu, B; Li, X; Shi, J; Tan, L; Zhou, H; Zou, X, 2020) |
"An 18-year-old patient had postpartum hemorrhage after a normal delivery." | 1.46 | Posterior reversible encephalopathy syndrome after postpartum hemorrhage and uterine artery embolization: A case report. ( Jin, Z; Liu, W; Shen, L; Shi, F; Shi, L; Shi, Y; Wu, D; Yang, X, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hu, B | 1 |
Zhou, H | 1 |
Zou, X | 1 |
Shi, J | 1 |
Li, X | 1 |
Tan, L | 1 |
Shi, F | 1 |
Shen, L | 1 |
Shi, Y | 1 |
Shi, L | 1 |
Yang, X | 1 |
Jin, Z | 1 |
Liu, W | 1 |
Wu, D | 1 |
1 trial available for midazolam and Postpartum Hemorrhage
Article | Year |
---|---|
A Comparison of Dexmedetomidine and Midazolam for the Prevention of Postoperative Nausea and Vomiting Caused by Hemabate in Cesarean Delivery: A Randomized Controlled Trial.
Topics: Adult; Cesarean Section; Dexmedetomidine; Female; Humans; Injections, Intravenous; Midazolam; Postop | 2020 |
1 other study available for midazolam and Postpartum Hemorrhage
Article | Year |
---|---|
Posterior reversible encephalopathy syndrome after postpartum hemorrhage and uterine artery embolization: A case report.
Topics: Adolescent; Anticonvulsants; Diazepam; Female; Humans; Hypnotics and Sedatives; Magnetic Resonance I | 2017 |